Fred Hassan insider trades
Open-market stock purchases and sales by Fred Hassan, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since May 1, 2012.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +202%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Mar 13, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Mar 10, 2026 | PGEN Precigen, Inc | Bought (not open market) | $63K |
| Mar 10, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Mar 10, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc | Bought (not open market) | — |
| Jan 2, 2026 | EYPT EyePoint, Inc | Bought (not open market) | — |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc | Bought (not open market) | $500K |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc | Bought (not open market) | $1M |
Companies traded
- BBIO BridgeBio Pharma, Inc: 1 buy, last Jun 22, 2026
- PGEN Precigen, Inc: 1 buy, last Mar 13, 2026
- COCP Cocrystal Pharma, Inc: other filings, last Jan 9, 2026
- EYPT EyePoint, Inc: other filings, last Jan 2, 2026
- RXDX Prometheus Biosciences, Inc: other filings, last Jun 16, 2023
- AMGN Amgen Inc: 2 buys, last May 5, 2020
- TWX Warner Media, LLC: other filings, last Jun 14, 2018
- XON Intrexon Corp: 1 buy, last Mar 23, 2018
- VRX Valeant Pharmaceuticals International, Inc: 1 buy, last Aug 29, 2013
- AVP Avon Products Inc: other filings, last May 3, 2012